AI consulting in New York provides strategic guidance across the most complex enterprise AI landscape in the Western Hemisphere. Financial services firms managing trillions in assets navigate SEC, FINRA, OCC and NYDFS requirements that govern how automated systems interact with financial data, make recommendations and execute transactions. SR 26-2, issued April 17, 2026, supersedes SR 11-7 and SR 21-8 as nonbinding supervisory guidance for model risk management, not enforceable standards or prescriptive requirements. It covers traditional statistical, quantitative and non-generative AI models; generative and agentic AI are not within the scope of this guidance (attachment footnote 3), so banks govern those tools under their own risk management policies. Media companies from publishers to streaming platforms evaluate how AI changes content creation, distribution and monetisation. Healthcare systems including Mount Sinai, NYU Langone and NewYork-Presbyterian evaluate clinical AI, assessing clinical validity (validated performance in the intended population and use producing clinically meaningful patient-relevant outcomes) and clinical utility (whether the tool changes clinical decisions in practice within a safe, usable workflow integration), alongside HIPAA, FDA and institutional review requirements. NYDFS requirements apply to licensed covered entities across insurance underwriting, banking and financial services; a third-party vendor may independently hold its own licence but is not automatically a covered entity by designation alone. LL144 governs automated employment decision tools substantially assisting hiring and promotion, with employer and agency duties including independent bias audit, publication and notice requirements. FINRA and SEC broker-dealer scope and Rule 17a-4 WORM or qualifying audit-trail alternative govern record retention. NY SHIELD Act addresses security and breach protections for statutory private information with defined categories and respective role-based obligations. ZTABS provides AI consulting in New York, remote-first by design with an office in Houston, Texas.
Our AI development services and automation and integration services complement New York AI consulting.
New York AI consulting at a glance
| Industry | Advisory focus | Key considerations |
|---|
| Financial services | Trading, risk, compliance, operations | SEC, FINRA, bank MRM governance, NYDFS |
| Media and advertising | Content, distribution, rights, ad tech | Guild agreements, content sensitivity |
| Healthcare | Clinical AI, operations, population health | HIPAA, FDA, clinical validation |
| Legal services | Document review, research, contracts | Professional responsibility, confidentiality |
| Real estate | Valuation, operations, portfolio analytics | Market complexity, multi-stakeholder |
Financial services advisory
Trading and quantitative advisory evaluating how large language models and AI can enhance existing quantitative strategies. Processing earnings call transcripts, SEC filings and news flow for trading signals. Evaluating LLM approaches, designing integration architectures and managing the risk of deploying language models in trading systems where errors have immediate financial consequences. Addressing model risk governance informed by SR 26-2 nonbinding supervisory guidance for traditional statistical and quantitative models; generative and agentic AI fall outside its scope and are governed by the bank's own risk management policies.
Credit and lending advisory evaluating AI for credit risk modelling, loan origination and underwriting. Ensuring AI credit models comply with ECOA fair lending requirements and adverse action notification obligations. Addressing model governance and the gap between model development and production deployment that commonly stalls credit AI initiatives.
Compliance advisory evaluating AI for AML surveillance, regulatory reporting automation and compliance monitoring. Assessing where AI improves detection rates versus existing rules-based systems. Evaluating false positive reduction opportunities that free compliance analyst capacity.
Insurance advisory evaluating AI for underwriting, claims processing and customer service automation. Addressing NYDFS requirements for licensed insurance entities including algorithmic underwriting guidelines and rate-setting oversight. Evaluating AI vendor products against actual operational requirements and total cost of ownership.
Need AI consulting for New York financial services?
Share your regulatory environment, operational challenges and strategic AI questions.
Media and advertising advisory
Content intelligence advisory evaluating AI for content creation workflows, post-production automation, metadata enrichment and rights management. Addressing guild agreement provisions and positioning AI as efficiency tools that augment creative work rather than replace creative workers.
Distribution and marketing advisory evaluating AI for recommendation optimisation, audience targeting, marketing spend optimisation and content personalisation. Assessing where AI genuinely improves distribution versus where hype exceeds current capability.
Advertising advisory evaluating AI for campaign optimisation, creative testing, media buying and audience development. Addressing the advertising holding companies' need to demonstrate measurable AI improvement in campaign performance.
Healthcare advisory
Clinical AI roadmap evaluating AI for diagnostic imaging, clinical decision support, predictive analytics and clinical documentation. Assessing clinical validity (validated performance in the intended population and use producing clinically meaningful patient-relevant outcomes compared to current practice), clinical utility (whether the tool changes clinical decisions in practice within a safe, usable workflow integration) and regulatory pathway (FDA clearance requirements for AI and ML-based software as a medical device). Addressing workflow integration to prevent the failure mode where technically impressive tools are built but never adopted by clinicians.
Operational AI assessment evaluating operational AI for scheduling, patient flow, revenue cycle and supply chain. Prioritising use cases by financial impact and implementation feasibility. Addressing the specific challenges of serving New York's diverse patient population.
AI governance for healthcare establishing governance frameworks defining how AI tools are evaluated, validated, deployed and monitored. Addressing algorithmic bias assessment and physician oversight requirements.
Illustrative Example
Hypothetical: New York investment bank AI strategy engagement
A mid-tier New York investment bank that had launched several AI initiatives over two years with minimal results (chatbot handling few inquiries, credit risk model stalled in model risk management review, document extraction introducing quality issues) would engage AI consulting. Assessment would find models built by a small data science team with no version control, no automated testing and no deployment automation, the gap between development and production being the primary bottleneck, the highest-value use cases different from those already pursued, and the credit risk model documentation not meeting the bank's own model risk management policy informed by SR 26-2 guidance. Strategy would redesign the AI programme around production deployment capability, prioritise use cases by actual value and feasibility, establish MLOps infrastructure, fix MRM documentation to clear the approval backlog, and create a governance framework. Advisory cost drivers include regulatory complexity, organisational breadth, technology infrastructure assessment depth and governance framework requirements. No guaranteed ROI, false positive reduction or specific deployment timeline.
This is a hypothetical scenario for illustration. Actual scope, timeline and cost depend on your requirements.
Advisory cost drivers
AI consulting engagements are scoped by advisory complexity. There is no published cost guide for AI consulting advisory. Key cost drivers include:
| Driver | Impact |
|---|
| Regulatory environment | SEC, FINRA, NYDFS, HIPAA compliance complexity |
| Organisational complexity | Number of business units and stakeholders |
| Technology assessment depth | Infrastructure, data and model evaluation scope |
| Use case portfolio | Number of AI opportunities analysed |
| Governance requirements | Model risk, clinical AI or compliance framework |
| Vendor evaluation | Number of technology options assessed |
| Change management | Organisational adoption planning depth |
| Implementation roadmap | Phased plan with milestone and success metric design |
Where AI consulting identifies implementation opportunities, actual AI development or AI agent development build projects can be separately scoped with published cost guides.
Planning AI strategy for your New York enterprise?
Share your regulatory environment, organisational complexity, use case portfolio and governance requirements so we can scope this advisory engagement.
Evaluating a proposal
| Criterion | What to verify |
|---|
| Financial regulatory depth | Bank MRM governance informed by SR 26-2 nonbinding guidance (traditional models in scope; generative/agentic AI governed by bank's own policies), SEC algorithmic trading, ECOA fair lending, NYDFS licensed-entity requirements |
| Production deployment track | Strategy-to-production pathway, MLOps infrastructure planning, model governance beyond documentation |
| Clinical AI assessment | Clinical validity and clinical utility evaluation, FDA SaMD pathway, workflow integration approach, physician oversight design |
| Media and content understanding | Guild agreement awareness, content sensitivity handling, distribution and rights management AI evaluation |
| Advisory independence | Vendor-neutral recommendations, no product-tied consulting, transparent advisory cost driver scoping |
| Organisational change capability | Stakeholder alignment, change management planning, talent strategy alongside technical recommendations |
When this engagement is not the right fit
- This engagement does not include licensed financial advisory, legal counsel or medical professional services. Where your project involves activities requiring those qualifications, you retain the appropriately licensed professionals; the agreed AI advisory work supports and integrates with their processes.
- You need full-time embedded AI staff rather than scoped strategic advisory.
- You need guaranteed financial returns, compliance outcomes or clinical results. AI consulting identifies opportunities and reduces risk but does not guarantee specific numerical results.
Risks in New York AI consulting
Regulatory complexity. Multi-layered regulatory environment (SEC, FINRA, NYDFS, state law) creates compliance considerations embedded in every AI recommendation. Requirements evolve; the strategy must maintain compliance flexibility.
Organisational dynamics. AI implementations in New York often fall short due to organisational factors including misaligned stakeholder incentives, inadequate change management or insufficient executive sponsorship alongside technical and data challenges. Consulting must address these dynamics directly.
Production gap. The distance between a working proof-of-concept model and a reliable production AI system encompasses MLOps, monitoring, governance and organisational integration. Strategy without production pathway creates expensive experiments.
What AI consulting delivers
Strategic AI audit. Mapping current AI capabilities, identifying highest-value use cases based on revenue impact and feasibility, assessing regulatory constraints specific to industry and operations, evaluating data infrastructure readiness, and producing prioritised implementation roadmaps with success metrics. A hedge fund audit examines signal generation pipelines and model governance; a hospital audit examines clinical workflow integration and EHR data accessibility.
Model risk management. For financial services, addressing model risk governance informed by SR 26-2 (April 17, 2026), which supersedes SR 11-7 and SR 21-8 as nonbinding supervisory guidance covering traditional statistical and quantitative models. Generative and agentic AI are not within its scope (attachment footnote 3) and are governed by the bank's own risk management policies. Many AI initiatives stall in model risk management review not because of model quality but because documentation does not meet the bank's policy requirements. Consulting does not guarantee clearing an approval backlog or regulatory acceptance.
Vendor evaluation. Assessing AI vendors and platforms against specific requirements. Evaluating claims against capabilities, integration requirements and total cost of ownership. Protecting organisations from vendor overcommitments.
Governance framework. Establishing AI governance appropriate for the industry. Model risk management for banking, clinical AI governance for healthcare, content AI governance for media. Defining evaluation, validation, deployment and monitoring processes.
Talent and capability. Evaluating build versus buy versus partner decisions for AI capability. Designing team structures that deliver operational AI rather than isolated research. Building internal capability over time through knowledge transfer. Our DevOps services and API development services complement implementation. ZTABS builds custom white-label AI products for clients to brand and resell.
Legal services advisory
Document review and research advisory evaluating AI for legal document review, contract analysis, legal research and matter management. Addressing professional responsibility implications including attorney work product, privilege considerations and the ethical obligations of lawyers using AI-assisted tools. Law firms are sophisticated buyers but cautious adopters requiring consulting that addresses both opportunity and professional responsibility.
Contract intelligence advisory evaluating AI for contract analysis, clause identification, risk flagging and portfolio management across large contract inventories. Assessing accuracy requirements for legal contexts where false negatives carry malpractice risk and false positives create unnecessary review burden.
Litigation support advisory evaluating AI for e-discovery, predictive coding and litigation analytics. Addressing the specific requirements of New York state and federal courts for technology-assisted review and the defensibility of AI-driven document review methodologies.
Real estate advisory
Portfolio analytics advisory evaluating AI for property valuation, market analysis, tenant engagement and energy optimisation across commercial real estate portfolios. Addressing the complexity of Manhattan's commercial market with over 500 million square feet of office space.
Property operations advisory evaluating AI for building management, maintenance optimisation, tenant services and sustainability reporting. Assessing the operational efficiency opportunities across multi-building portfolios.
Additional advisory domains
Retail and consumer advisory. Evaluating AI for inventory management, demand forecasting, pricing optimisation and customer experience. Addressing the competitive dynamics of New York's retail market and the operational complexity of multi-location retail operations.
Education advisory. Evaluating AI for student administration, admissions, research management and alumni engagement across New York's universities. Addressing FERPA requirements and the administrative complexity of large academic institutions.
Government advisory. Evaluating AI for New York City and state agency operations. Addressing the governance, transparency, equity and accountability requirements of public sector AI deployment.
Nonprofit advisory. Evaluating AI for fundraising, programme management, volunteer coordination and impact measurement across New York's nonprofit sector. Addressing the operational constraints and mission-driven priorities of nonprofit organisations.
Workflow suitability assessment
Deterministic versus AI. Many workflows identified as AI opportunities are better served by deterministic automation, better dashboards or process improvement. Consulting distinguishes where AI genuinely adds value versus where simpler approaches are sufficient and less expensive.
Data readiness. Evaluating data assets against proposed AI applications. Many New York enterprises have massive data assets in trading systems, EHR platforms and content management systems but need data engineering before AI can use them effectively.
Build versus buy. For each AI opportunity, evaluating custom development, vendor products, API providers and platform solutions. Financial services firms often need custom development for proprietary trading signals but can use vendor solutions for compliance monitoring.
Human judgment boundaries. Defining which decisions remain with human professionals and which agent actions require approval. Financial decisions, clinical recommendations, legal advice and editorial judgment require human accountability. AI consulting defines these boundaries clearly.
Model evaluation. Evaluating AI models against representative held-out tasks and simpler baselines. Assessing failure costs and uncertainty. Establishing deployment monitoring and performance tracking. Human review reduces risk but never guarantees zero hallucinations, bias or errors.
Observability design. Designing monitoring with minimised sensitive data rather than logging every raw prompt. Addressing vendor retention and training versus inference terms, subprocessor requirements and model version change evaluation.
Implementation phasing. Designing phased rollouts starting with narrow high-value use cases. Each phase delivering measurable results and building organisational confidence before expanding scope. Quarterly milestones with clear success criteria.
Organisational integration. Embedding AI capabilities into existing workflows rather than creating parallel systems that teams ignore. Addressing adoption barriers, training requirements and the change management that sustains AI programmes beyond initial enthusiasm.
Ready for AI consulting in New York?
Share your financial services, media or healthcare operations and AI objectives.